# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-140991
Filing Date
2018-04-30
Accepted
2018-04-30 08:36:55
Documents
3
Effectiveness Date
2018-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d554102ddefa14a.htm | DEFA14A | 18498
2 | GRAPHIC | g554102img01.jpg | GRAPHIC | 342802
3 | GRAPHIC | g554102img02.jpg | GRAPHIC | 296276
| Complete submission text file | 0001193125-18-140991.txt |  | 900179

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33221 | Film No.: 18786831
SIC: 2834 Pharmaceutical Preparations